78.7 F
Laguna Hills
Friday, Jun 21, 2024
-Advertisement-

INNOVATION: MICHAEL MCGARRITY

CEO, MDXHEALTH

WHY: Exec helming precision diagnostics company with its U.S. HQ and laboratories in Irvine. Diagnostics products aim to improve early detection of prostate cancer in a noninvasive manner and reduce the number of false negatives.

IN THE NEWS: Acquired a prostate cancer business for up to $100M from Madison, Wis.-based Exact Sciences Corp. Says the acquisition now allows the company to provide “the most comprehensive menu of advanced molecular tests for urology in prostate cancer.”

NOTABLE: Company raised around $45M in an initial public offering late last year, in part “to expand our menu in prostate cancer and other urologic diseases.”

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-